fv-100
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started May 1, 2009 (NCT00900783)
Timeline
Indications
Mechanism of action
- DNA polymeraseINHIBITOR
POL inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- fv-100
- fv-100
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02412917 | Phase 3 | Jun 1, 2015 | Hepion Pharmaceuticals |
| NCT02322957 | Phase 1 | Feb 1, 2015 | Hepion Pharmaceuticals |
| NCT00900783 | Phase 2 | May 1, 2009 | Bristol-Myers Squibb |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hepion Pharmaceuticals | For profit | 2 | 2 | 2 | 2015 |
| Bristol-Myers Squibb | For profit | 1 | 1 | 1 | 2009 |
2 organizations
Page 1 / 1